There are currently 96 ongoing clinical trials involving Vitiligo
Of the 96 trials,45 trials are in Phase II
Furthermore, 19 trials are in Phase III
The global pharmaceutical industry is steadily developing new drugs for Vitiligo, a Dermatology condition. The largest number of ongoing clinical trials for Vitiligo is conducted in the Asia-Pacific region. North America and Middle East and Africa are among some of the other prominent regions engaged in Vitiligo-related drug trials.
Pfizer Inc: The leading ongoing Vitiligo related clinical trial sponsor
Pfizer Inc is the top sponsor for Vitiligo-related ongoing clinical trials.
Incyte Corp, Postgraduate Institute of Medical Education and Research, Cairo University and Ain Shams University are among other notable clinical trial sponsors involved in Vitiligo. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
Marketed Drugs involving Vitiligo
Aminobenzoic acid and methoxsalen (Melanocyl), Bifonazole (Mycospor, Canesten, Mycospor Onychoset, Meike, Canesten Unidie, Canesderm Pie, Canestene Derm, Canespie, Canesten Bifonazole, Canesten Pro) and Carpronium chloride (Arovics) are among the key marketed drugs involving Vitiligo.
Aminobenzoic acid and methoxsalen (Melanocyl) is fixed dose combination acts as an anti-vitiligo agent. It functions via 5- DNA Synthesis Inhibitor mechanism of action. Aminobenzoic acid is formulated as ointment for topical application. It is indicated for the treatment of psoriasis and vitiligo. Aminobenzoic acid is marketed solely in India by Franco-Indian Pharmaceuticals Pvt Ltd.
Bifonazole is an azole antifungal drug. It functions via Lanosterol 14 Alpha Demethylase Inhibitor mechanism of action. Bifonazole is formulated as cream, ointment, gel, spray, powder, shampoo and solution for topical application. Bifonazole was first approved in 1982 and is marketed globally in Australia, UK, China, Japan, Russia and Germany by several prominent pharma giants including Bayer Australia Ltd.
United States of America
Ireland
United States of America
United States of America
Japan
United Kingdom
United States of America
United States of America
Australia
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer